Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Seubert

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1Marion S Buckwalter, Bronwen S Coleman, Manuel Buttini, et al.
Neuron|June 20, 2014
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibitionAdrienne L Orr, Jesse E Hanson, Dong Li, et al.
The American Journal of Pathology|August 28, 2004
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceThierry Bussière, Frédérique Bard, Robin Barbour, et al.
Annals of Neurology|September 1, 2005
Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodiesMichael Lee, Frederique Bard, Kelly Johnson-Wood, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 4, 2008
Immunotherapy reduces vascular amyloid-beta in PDAPP miceSally Schroeter, Karen Khan, Robin Barbour, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 24, 2012
Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specificWagner Zago, Manuel Buttini, Thomas A Comery, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's diseaseManuel Buttini, Eliezer Masliah, Robin Barbour, et al.
Neuron|November 7, 2025
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson's DiseaseEliezer Masliah, Edward Rockenstein, Anthony Adame, et al.
Plos One|January 10, 2013
AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrilsJonathan S Wall, Stephen J Kennel, Angela Williams, et al.
The American Journal of Pathology|January 15, 2013
Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synucleinDora Games, Peter Seubert, Edward Rockenstein, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1Marion S Buckwalter, Bronwen S Coleman, Manuel Buttini, et al.
Neuron|June 20, 2014
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibitionAdrienne L Orr, Jesse E Hanson, Dong Li, et al.
The American Journal of Pathology|August 28, 2004
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceThierry Bussière, Frédérique Bard, Robin Barbour, et al.
Annals of Neurology|September 1, 2005
Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodiesMichael Lee, Frederique Bard, Kelly Johnson-Wood, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 4, 2008
Immunotherapy reduces vascular amyloid-beta in PDAPP miceSally Schroeter, Karen Khan, Robin Barbour, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 24, 2012
Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specificWagner Zago, Manuel Buttini, Thomas A Comery, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's diseaseManuel Buttini, Eliezer Masliah, Robin Barbour, et al.
Neuron|November 7, 2025
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson's DiseaseEliezer Masliah, Edward Rockenstein, Anthony Adame, et al.
Plos One|January 10, 2013
AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrilsJonathan S Wall, Stephen J Kennel, Angela Williams, et al.
The American Journal of Pathology|January 15, 2013
Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synucleinDora Games, Peter Seubert, Edward Rockenstein, et al.
Pageof 4